Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2025 EPS estimates for Calumet Specialty Products Partners in a research report issued to clients and investors on Monday, January 13th. HC Wainwright analyst A. Dayal expects that the oil and gas company will earn ($0.34) per share for the quarter. HC Wainwright currently has a “Buy” rating and a $33.00 target price on the stock. The consensus estimate for Calumet Specialty Products Partners’ current full-year earnings is ($2.87) per share. HC Wainwright also issued estimates for Calumet Specialty Products Partners’ Q2 2025 earnings at ($0.38) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at $1.88 EPS, FY2025 earnings at $1.04 EPS, FY2026 earnings at $2.66 EPS, FY2027 earnings at $3.10 EPS and FY2028 earnings at $3.35 EPS.
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) last posted its quarterly earnings data on Friday, November 8th. The oil and gas company reported ($1.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.59) by ($0.59). The business had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $888.36 million. During the same period last year, the firm earned $0.03 earnings per share. The company’s revenue for the quarter was down 4.3% compared to the same quarter last year.
Get Our Latest Analysis on Calumet Specialty Products Partners
Calumet Specialty Products Partners Price Performance
Calumet Specialty Products Partners stock opened at $18.16 on Thursday. The business has a 50 day simple moving average of $21.37 and a 200-day simple moving average of $18.77. Calumet Specialty Products Partners has a 12 month low of $9.97 and a 12 month high of $25.29. The stock has a market capitalization of $1.56 billion, a PE ratio of -6.58 and a beta of 1.90.
Institutional Investors Weigh In On Calumet Specialty Products Partners
A number of institutional investors and hedge funds have recently modified their holdings of CLMT. Founders Financial Alliance LLC increased its position in shares of Calumet Specialty Products Partners by 8.4% in the second quarter. Founders Financial Alliance LLC now owns 48,400 shares of the oil and gas company’s stock valued at $777,000 after buying an additional 3,750 shares in the last quarter. DRW Securities LLC acquired a new stake in Calumet Specialty Products Partners in the 2nd quarter valued at about $898,000. Finally, Creative Planning increased its holdings in Calumet Specialty Products Partners by 46.4% during the 2nd quarter. Creative Planning now owns 62,459 shares of the oil and gas company’s stock valued at $1,002,000 after acquiring an additional 19,800 shares in the last quarter. Institutional investors and hedge funds own 34.41% of the company’s stock.
Insider Buying and Selling at Calumet Specialty Products Partners
In other Calumet Specialty Products Partners news, Director Jennifer Straumins sold 37,861 shares of the stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $21.42, for a total value of $810,982.62. Following the completion of the transaction, the director now directly owns 1,184,589 shares of the company’s stock, valued at approximately $25,373,896.38. This trade represents a 3.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.91% of the stock is owned by corporate insiders.
About Calumet Specialty Products Partners
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Featured Stories
- Five stocks we like better than Calumet Specialty Products Partners
- Using the MarketBeat Dividend Tax Calculator
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- What is a support level?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.